Member Info for Hope1968

Https://www.amazon.com/Eroxonin-Penile-Re-Vitalize-Restore-Cavernosum/dp/B0D9PCG3PJ

Dosan it is on USA site but not under name it’s slightly different from what I seen a slight change of name and new packaging only thing you can spot is the med 3000 which is the same name as the product in medical terms try look for a product called Eroxonion.

Maybe Italian but I see it that it needed a different approach also maybe the American distributor’s have now got there act together also is there a possible franchise on the card where they will buy out the product for the American market lock stock an barrel?

Quick deal of maybe 45 million?

Roughly over 109K not stupid money I would say?

Not showing on lse but advfn two transactions at 09.32 which only showed after trading.

To buys over 13 million this morning at 39 and 40 something on the cards?

Was looking on US Amazon when came across similar name

Eroxonin Male Penile Health Re-Vitalize Relief Cream. Restore Corpus Cavernosum for Men!

More like this

Eroxonin Male Penile Health Re-Vitalize Relief Cream. Restore Corpus Cavernosum for Men!

Didn’t know if it was the same until I seen the number Med 3000

Looks like new packaging which looks great maybe they getting there act together in the marketing team.

Futura Medical PLC - Clinical trial data presented at SMSNA #FUM https://www.voxmarkets.co.uk/rns/announcement/840c6b67-69ef-4d13-93f7-eb52aa5d8ea9 #voxmarkets undefined

When it starts hitting 52 week high I will be more happy than being dormant at the moment we need some figures published we must be due at least Europe figures I can understand we will being waiting for US so why have we not been given any figures on sales where is Q3?

Came up on my screen as a buy.

I agree dosa that it will double where it is from today more like 75/85 mark.

We know on testing that this product is not for everyone and it will be a hit and miss for certain members from the public who don’t like the idea of alternatives that have side effects so not for everyone but fum need to with its marketing team who seem pretty poor need to get the act together and do

Some sort of campaign that explains it more for the customers to me 60% is a good catchment and we are going to have bad reviews but we also need reviews from individuals who it has worked on and many will not post on a something that is a sensitive subject but they will come back and purchase more but we need to hit people with a campaign that out lays all this rather individuals who will just look at bad reviews but like anything time will tell and we can build up a client’s base that will come back and repurchase.

Must be a lot of Linp dicks shop at Walmart also noticed it’s more expensive than Amazon.

To be honest going by testing this product is not for everyone as it states 62% showed that it worked for them so I expect some negative reviews as well as some positive so nir a deal breaker.

Why has this product now showing nothing on Amazon down to 16 from 9 but no sale figures what is going on?

I wonder if FUM who seem not to bothered in the video to deal with the marketing of there product is a good idea maybe money is not freely available for a big market campaign as yet and sales are good enough to keep the company ticking over but will be interesting to see world wide sales soon maybe 3 months to put some type figure on next level of getting the product as well known as oral medication gets? I personnly don’t know the deal that was done by FUM to get product noticed but it’s still early days.

Totally agree but rember this is just USA before we factor Europe Africa and Middle East yes US is the market we want bar China but I’m really disappointed with company on a few things but they are just a pharma company we hoped the marketing would of been better now on sale in US.

Well going by Amazon number 2 sold 10k amd number 1 sold 70k which are more established but rember Amazon isn’t the only way you can buy this it’s also available over the counter don’t get me wrong I think marketing as been handled very poorly and could of been better maybe we get answers from the marketing team why? But way I look at it let’s say it sellls 10k every month for a year the company makes profits also this is avery competitive market and time will tell a lot longer than a month like to see what sales are after 3 months.

Nity Delta view: As we have stated before, Futura Medical’s investment case has shifted firmly onto commercial execution. The highly successful initial launches of Eroxon, its novel topical gel for ED (erectile dysfunction), by partner Cooper Consumer Health in the UK and Belgium are being followed by roll-outs across the major European markets. Other geographies have also successfully launched. However, in our view, it is the US that could prove transformational as commercial success in the US would put Futura firmly on the path towards sustainable and growing profitability. Therefore, increasing clarity on potential launch timelines is reassuring, given limited visibility previously. Eroxon offers a unique proposition within ED, being a clinically proven, fast-acting, and safe product that can be easily bought over-the-counter. The market for ED treatments is significant and Eroxon appears ideally placed to carve a sizeable niche for itself. Our current Futura Medical valuation, based on conservative assumptions, is £371m, equivalent to 123p per share, with the US opportunity worth more than Europe and Other Regions combined.

Https://www.prnewswire.com/news-releases/haleon-announces-the-launch-of-eroxon-the-first-and-only-fda-cleared-otc-gel-for-erectile-dysfunction-available-for-us-preorder-without-a-prescription-302235236.html

Darthinvester over 9k+ should be at number 9 on Amazon charts if you want to be exact and I don’t mind them figures every month but I do agree that marketing as not been the best.